Loading
Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.
Direct links plus the targets, companies, and technologies of this cancer's products.
Shares KEYNOTE-024 & KEYNOTE-189, BRAF V600E-mutant non-small-cell lung cancer, Non-small cell lung cancer (KEGG map), ALK-positive non-small-cell lung cancer and the tags subtype-page, lung.
Shares Adenocarcinoma of the lung, BRAF V600E-mutant non-small-cell lung cancer, Non-small cell lung cancer (KEGG map), ALK-positive non-small-cell lung cancer and the tags subtype-page, lung.
Shares BRAF V600E-mutant non-small-cell lung cancer, Non-small cell lung cancer (KEGG map), ALK-positive non-small-cell lung cancer, Pemetrexed and the tags subtype-page, lung.
Shares BRAF V600E-mutant non-small-cell lung cancer, Non-small cell lung cancer (KEGG map), ALK-positive non-small-cell lung cancer, Pemetrexed and the tags subtype-page, lung.
Shares BRAF V600E-mutant non-small-cell lung cancer, Non-small cell lung cancer (KEGG map), ALK-positive non-small-cell lung cancer, Pemetrexed and the tags subtype-page, lung.
Shares Martin Reck, Maintenance therapy, PD-1 / PD-L1 immune checkpoint & T-cell activation, Atezolizumab and the tags subtype-page, lung.
Shares PD-1 / PD-L1 immune checkpoint & T-cell activation, PD-L1, Carboplatin, Immune checkpoint inhibitors and the tags subtype-page, lung.
Shares Squamous cell carcinoma of the lung, Adenocarcinoma of the lung, Pemetrexed, Carboplatin and the tags subtype-page, lung.
The same record for scripts and assistants; checked 2026-09-17. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.